• Science & Technology
• Health & Medicine

Tracking unstable chromosomes helps predict lung cancer’s return

The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse. The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse.

26 April 2017

• Health & Medicine

CRISPR genome editing and immunotherapy – the early adopter

How is CRISPR genome editing helping harness the power of immunotherapy? How is CRISPR genome editing helping harness the power of immunotherapy?

21 April 2017

• Science & Technology
• Health & Medicine

Taking advantage of cancers’ abnormal metabolism could lead to a new way to ‘starve’ tumours

Our researchers in Glasgow might have found a way to shut down certain cancer cells’ fuel supply with a specially designed diet. Our researchers in Glasgow might have found a way to shut down certain cancer cells’ fuel supply with a specially designed diet.

19 April 2017

• Science & Technology

Amino acids in diet could be key to starving cancer

Cutting out certain amino acids – the building blocks of proteins – from the diet of mice slows tumour growth and prolongs survival. Cutting out certain amino acids – the building blocks of proteins – from the diet of mice slows tumour growth and prolongs survival.

19 April 2017

• Science & Technology

CRT pioneer fund, Cancer Research UK and NCI collaborate to boost research against the ‘undruggable’ RAS

Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute. Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute.

19 April 2017

• Science & Technology

Targeting cancer spread: keeping breast tumours under LOX and key

Find out how our scientists are developing a way to target a troublesome cancer molecule, LOX. Find out how our scientists are developing a way to target a troublesome cancer molecule, LOX.

18 April 2017

• Health & Medicine
• Science & Technology

News digest – immunotherapies showing promise, breast cancer drug approved for Scotland, childhood cancer rates, and… killer sofas?

Immunotherapies show promise but not for every tumour, calls for boys to get the HPV vaccine and... what's killer about sofas? Find out in the news digest. Immunotherapies show promise but not for every tumour, calls for boys to get the HPV vaccine and... what's killer about sofas? Find out in the news digest.

14 April 2017

• Science & Technology

Cancer living outside the body, unravelling a cellular mystery and targeting ‘sleeping’ cancer cells: our latest cutting-edge science projects

Our rapid turn-around funding scheme aims to fund high-risk research that we wouldn’t normally fund. Our rapid turn-around funding scheme aims to fund high-risk research that we wouldn’t normally fund.

14 April 2017

• Science & Technology
• Health & Medicine

Blood tests, microbes, immunotherapy and more: AACR 2017’s hottest topics

At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics. At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics.

13 April 2017

• Health & Medicine

Blocking growth of tumour blood vessels could boost immunotherapy

Immunotherapy treatment could be improved by blocking molecules that help tumour blood vessels grow, according to two new lab-based studies. Immunotherapy treatment could be improved by blocking molecules that help tumour blood vessels grow, according to two new lab-based studies.

12 April 2017

• Science & Technology

Study suggests why an immunotherapy drug works in some melanoma patients but not in others

Matching tumour size to the body’s immune response could help doctors tailor immunotherapy treatments for melanoma patients whose disease has spread. Matching tumour size to the body’s immune response could help doctors tailor immunotherapy treatments for melanoma patients whose disease has spread.

12 April 2017

• Science & Technology

9 burning questions about CRISPR genome editing answered

In this post we’ll be exploring the gene editing technology CRISPR by answering some of the most common questions that pop up. In this post we’ll be exploring the gene editing technology CRISPR by answering some of the most common questions that pop up.

11 April 2017